Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 1. Glycolates.
The 38 esters in Table I were prepared from the four isomeric 2-tropanols and a variety of racemic glycolic acids and their optical isomers. Anticholinergic activity in mice was measured in the peripheral nervous system (mydriasis) and in the central nervous system (anti-tremorine) and compared with that of atropine, scopolamine, and racemic 2-quinuclidinyl benzilate. The results (Table III) showed that several esters (such as 8, 12, 14, and 21) had significantly greater activity in both the peripheral and central nervous systems than did the reference compounds. Esters of (+)-2alpha-tropanol were more potent than those of either its epimer (-)-2beta-tropanol or its optical isomer(-)-2alpha-tropanol. Esters derived from (-)-glycolic acids were uniformly more potent than those from the (+)-glycolic acids. Esters of (+)-2alpha-notropanol and five of its N-substituted derivatives had markedly decreased activity. Peripheral/central activity ratios and time-activity profiles for five active compounds are discussed and compared with those of the reference compounds.
D000818:Animals; D006016:Glycolates / Q000138:chemical synthesis / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009184:Mydriatics / Q000138:chemical synthesis; D010276:Parasympatholytics / Q000138:chemical synthesis*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013997:Time Factors; D014203:Tremorine / Q000037:antagonists & inhibitors; D014326:Tropanes / Q000138:chemical synthesis* / Q000494:pharmacology
D006016:Glycolates; D009184:Mydriatics; D010276:Parasympatholytics; D014326:Tropanes; D014203:Tremorine